Krystal Biotech, Inc. (BIT:1KRYS)
Italy
· Delayed Price · Currency is EUR 119.35
-4.60 (-3.71%)
At close: May 13, 2025
Krystal Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | 123.96 | 89.16 | 10.93 | -139.98 | -69.57 | -32.17 | Upgrade
|
| Depreciation & Amortization | 3.14 | 3.21 | 4.81 | 3.39 | 2.77 | 1.85 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -100 | - | - | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.06 | -7.78 | -7.28 | 0.1 | - | - | Upgrade
|
| Stock-Based Compensation | 53.31 | 49.13 | 39.93 | 33.23 | 15.32 | 3.27 | Upgrade
|
| Other Operating Activities | 5.45 | 4.15 | 1.32 | 0.03 | 1.04 | 0.01 | Upgrade
|
| Change in Accounts Receivable | -56.79 | -62.71 | -42.04 | - | - | - | Upgrade
|
| Change in Inventory | -11.06 | -11.91 | -4.48 | - | - | - | Upgrade
|
| Change in Accounts Payable | 1.19 | 1.01 | -0.1 | -1.25 | 0.71 | 0.78 | Upgrade
|
| Change in Other Net Operating Assets | 27.37 | 59.15 | 8.09 | 3.91 | 1.79 | 0.13 | Upgrade
|
| Operating Cash Flow | 138.5 | 123.42 | -88.8 | -100.57 | -47.94 | -26.08 | Upgrade
|
| Capital Expenditures | -9.18 | -4.24 | -11.8 | -52.98 | -68.34 | -14.84 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 100 | - | - | - | Upgrade
|
| Investment in Securities | -183.48 | -159.2 | -5.56 | -61.1 | -158.43 | 3.66 | Upgrade
|
| Investing Cash Flow | -192.23 | -163.44 | 82.64 | -114.08 | -226.77 | -11.18 | Upgrade
|
| Issuance of Common Stock | 17.89 | 32.4 | 203.5 | 36 | 355.65 | 118.02 | Upgrade
|
| Repurchase of Common Stock | -13.93 | -5.39 | -0.75 | -0.65 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -7.96 | - | Upgrade
|
| Financing Cash Flow | 3.97 | 27.01 | 202.75 | 35.35 | 347.69 | 118.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.47 | -0.46 | -0.16 | -0.04 | - | - | Upgrade
|
| Net Cash Flow | -50.24 | -13.46 | 196.43 | -179.35 | 72.98 | 80.76 | Upgrade
|
| Free Cash Flow | 129.32 | 119.18 | -100.6 | -153.55 | -116.27 | -40.93 | Upgrade
|
| Free Cash Flow Margin | 38.78% | 41.02% | -198.43% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | 4.33 | 4.01 | -3.63 | -6.02 | -5.24 | -2.18 | Upgrade
|
| Cash Income Tax Paid | 6.07 | 5.67 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | 76.74 | 92.96 | -74.61 | -90.02 | -85.35 | -19.98 | Upgrade
|
| Unlevered Free Cash Flow | 76.74 | 92.96 | -74.61 | -90.02 | -84.41 | -19.98 | Upgrade
|
| Change in Net Working Capital | 54 | 19.64 | 46.79 | -2.15 | -9.51 | -10.37 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.